Literature DB >> 10741562

1,3-Diarylcycloalkanopyrazoles and diphenyl hydrazides as selective inhibitors of cyclooxygenase-2.

Z Sui1, J Guan, M P Ferro, K McCoy, M P Wachter, W V Murray, M Singer, M Steber, D M Ritchie, D C Argentieri.   

Abstract

Novel 1,3-diarylcycloalkanopyrazoles 1, and diphenyl hydrazides 2 were identified as selective inhibitors of cyclooxygenase-2. The 1,3-diaryl substitution pattern of the pyrazole ring in 1 differentiates these compounds from most of the known selective COX-2 inhibitors that contain two aryl rings at the adjacent positions on a heterocyclic or a phenyl ring. Similarly, the two phenyl rings in 2 are also separated by three atoms. SAR of both phenyl rings in 1 and 2, and the aliphatic ring in 1 will be discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10741562     DOI: 10.1016/s0960-894x(00)00041-x

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Utility of novel 2-furanones in synthesis of other heterocyclic compounds having anti-inflammatory activity with dual COX2/LOX inhibition.

Authors:  Rania H Abd El-Hameed; Shahenda Mahgoub; Hend M El-Shanbaky; Mosaad S Mohamed; Sahar A Ali
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

2.  Continuous flow synthesis of Celecoxib from 2-bromo-3,3,3-trifluoropropene.

Authors:  Maria Ivanova; Julien Legros; Thomas Poisson; Philippe Jubault
Journal:  J Flow Chem       Date:  2021-10-05       Impact factor: 3.264

3.  Design, synthesis and biological evaluation of novel 1,3-diarylpyrazoles as cyclooxygenase inhibitors, antiplatelet and anticancer agents.

Authors:  Nazan Inceler; Yesim Ozkan; Nilufer Nermin Turan; Deniz Cansen Kahraman; Rengul Cetin-Atalay; Sultan Nacak Baytas
Journal:  Medchemcomm       Date:  2018-04-06       Impact factor: 3.597

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.